UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

The Lancet (British edition), 2009-06, Vol.373 (9679), p.1949-1957

2009

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years

24th International Papillomavirus Conference and Clinical Workshop,2007-11-03 - 2007-11-09, 2009-04, Vol.199 (7), p.926-935

2009

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

24th International Papillomavirus Conference and Clinical Workshop,2007-11-03 - 2007-11-09, 2009-04, Vol.199 (7), p.936-944

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Real-Time Multiplex Human Papillomavirus (HPV) PCR Assays with INNO-LiPA HPV Genotyping Extra Assay

Journal of Clinical Microbiology, 2011-05, Vol.49 (5), p.1907-1912

2011

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of type‐specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self‐collected specimens: Implications for vaginal self‐collection

International journal of cancer, 2010-09, Vol.127 (5), p.1151-1157

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Real-Time Multiplex Human Papillomavirus (HPV) PCR Assays with the Linear Array HPV Genotyping PCR Assay and Influence of DNA Extraction Method on HPV Detection

Journal of Clinical Microbiology, 2011-05, Vol.49 (5), p.1899-1906

2011

Link zum Volltext

Verfügbarkeit prüfen

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

The New England journal of medicine, 2007-05, Vol.356 (19), p.1928-1943

2007

Link zum Volltext

Verfügbarkeit prüfen

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

BMJ (British Medical Journal), 2010-07, Vol.341 (7766), p.c3493-239

International edition, 2010

Link zum Volltext

Verfügbarkeit prüfen

Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women

International journal of cancer, 2012-09, Vol.131 (6), p.1388-1395

2012

Link zum Volltext

Verfügbarkeit prüfen

Study Comparing Human Papillomavirus (HPV) Real-Time Multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV Genotyping PCR Assays

Journal of Clinical Microbiology, 2009-07, Vol.47 (7), p.2106-2113

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

JNCI : Journal of the National Cancer Institute, 2010-03, Vol.102 (5), p.325-339

2010

Link zum Volltext

Verfügbarkeit prüfen

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions

Cancer prevention research (Philadelphia, Pa.), 2009-10, Vol.2 (10), p.868-878

2009

Link zum Volltext

Verfügbarkeit prüfen

HPV genotypes in CIN 2‐3 lesions and cervical cancer: A population‐based study

International journal of cancer, 2007-12, Vol.121 (12), p.2682-2687

2007

Link zum Volltext

Verfügbarkeit prüfen

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus‐like‐particle vaccine in Latin American women

International journal of cancer, 2008-03, Vol.122 (6), p.1311-1318

2008

Link zum Volltext

Verfügbarkeit prüfen

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine

Vaccine, 2004-08, Vol.22 (23), p.3004-3007

2004

Link zum Volltext

Verfügbarkeit prüfen

Contribution of hydrogen bonding to lipid-lipid interactions in membranes and the role of lipid order: Effects of cholesterol, increased phospholipid unsaturation, and ethanol

Biochemistry (Easton), 1993-04, Vol.32 (14), p.3714-3721

1993

Link zum Volltext

Verfügbarkeit prüfen

Interaction of Protein Kinase C with Filamentous Actin: Isozyme Specificity Resulting from Divergent Phorbol Ester and Calcium Dependencies

Biochemistry (Easton), 2000-01, Vol.39 (2), p.271-280

2000

Link zum Volltext

Verfügbarkeit prüfen

Synergistic Activation of Protein Kinase Cα, -βI, and -γ Isoforms Induced by Diacylglycerol and Phorbol Ester: Roles of Membrane Association and Activating Conformational Changes

Biochemistry (Easton), 1999-03, Vol.38 (12), p.3804-3815

1999

Link zum Volltext

Verfügbarkeit prüfen

The modulation of protein kinase C activity by membrane lipid bilayer structure

The Journal of biological chemistry, 1994-02, Vol.269 (7), p.4866-4871

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Female
(22)
Humans
(22)
Biological And Medical Sciences
(19)
Adult
(18)
Adolescent
(17)
Human Papillomavirus
(16)
Cervical Cancer
(13)
Papillomavirus Infections - Prevention & Control
(13)
Medical Sciences
(12)
Papillomavirus Infections - Virology
(12)
Fundamental And Applied Biological Sciences. Psychology
(11)
Microbiology
(11)
Medical And Health Sciences
(10)
Medicin Och Hälsovetenskap
(10)
Virology
(10)
Infectious Diseases
(9)
Miscellaneous
(9)
Uterine Cervical Neoplasms - Prevention & Control
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

Comparison of Real-Time Multiplex Human Papillomavirus (HPV) PCR Assays with INNO-LiPA HPV Genotyping Extra Assay

Prevalence of type‐specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self‐collected specimens: Implications for vaginal self‐collection

Comparison of Real-Time Multiplex Human Papillomavirus (HPV) PCR Assays with the Linear Array HPV Genotyping PCR Assay and Influence of DNA Extraction Method on HPV Detection

Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital Diseases

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women

Study Comparing Human Papillomavirus (HPV) Real-Time Multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV Genotyping PCR Assays

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

HPV genotypes in CIN 2‐3 lesions and cervical cancer: A population‐based study

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus‐like‐particle vaccine in Latin American women

A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine

Contribution of hydrogen bonding to lipid-lipid interactions in membranes and the role of lipid order: Effects of cholesterol, increased phospholipid unsaturation, and ethanol

Prophylactic Efficacy of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Women with Virological Evidence of HPV Infection

Interaction of Protein Kinase C with Filamentous Actin: Isozyme Specificity Resulting from Divergent Phorbol Ester and Calcium Dependencies

Synergistic Activation of Protein Kinase Cα, -βI, and -γ Isoforms Induced by Diacylglycerol and Phorbol Ester: Roles of Membrane Association and Activating Conformational Changes

The modulation of protein kinase C activity by membrane lipid bilayer structure

Suchergebnisse filtern